Advertisement

Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach

      Abstract

      The diagnosis of breast cancer (BC) during pregnancy is uncommon. It has varied among different studies from 1:10,000 to 1:3000 of all pregnancies, with a median age of 33 years. Pregnancy-associated BC represents a challenge in terms of clinical management to guarantee both maternal and fetal security in choosing the right treatment. This situation is complex and requires a multidisciplinary approach, including the surgeon, anesthesiologist, oncologist, radiotherapist, psychologist, and maternal–fetal medicine specialist. In the present review, we examined the management of pregnancy-associated BC, focusing on pathophysiologic background, risk factors, diagnosis, staging procedures, anesthesia, surgical management, and systemic treatment.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Breast Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Siegel R.L.
        • Miller K.D.
        • Jemal A.
        Cancer statistics, 2018.
        CA Cancer J Clin. 2018; 68: 7-30
        • Ghiasvand R.
        • Adami H.O.
        • Harirchi I.
        • Akrami R.
        • Zendehdel K.
        Higher incidence of premenopausal breast cancer in less developed countries; myth or truth?.
        BMC Cancer. 2014; 14: 343
        • Stensheim H.
        • Møller B.
        • van Dijk T.
        • et al.
        Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study.
        J Clin Oncol. 2009; 27: 45-51
        • Pentheroudakis G.
        • Pavlidis N.
        Cancer and pregnancy: poena magna, not anymore.
        Eur J Cancer. 2006; 42: 126-140
      1. RCOG Green-top Guideline No. 12. Pregnancy and breast cancer. Royal College of Obstetricians and Gynaecologists; 2011.
        (Available at:) (Accessed: April 4, 2020)
        • Ruiz R.
        • Herrero C.
        • Strasser-Weippl K.
        • et al.
        Epidemiology and pathophysiology of pregnancy-associated breast cancer: a review.
        Breast. 2017; 35: 136-141
        • Beadle B.M.
        • Woodward W.A.
        • Middleton L.P.
        • et al.
        The impact of pregnancy on breast cancer outcomes in women < or = 35 years.
        Cancer. 2009; 115: 1174-1184
        • Albrektsen G.
        • Heuch I.
        • Hansen S.
        • Kvåle G.
        Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects.
        Br J Cancer. 2005; 92: 167-175
        • Cullinane C.A.
        • Lubinski J.
        • Neuhausen S.L.
        • et al.
        Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers.
        Int J Cancer. 2005; 117: 988-991
        • Asztalos S.
        • Gann P.H.
        • Hayes M.K.
        • et al.
        Gene expression patterns in the human breast after pregnancy.
        Cancer Prev Res (Phila). 2010; 3: 301-311
        • Asztalos S.
        • Pham T.N.
        • Gann P.H.
        • et al.
        High incidence of triple negative breast cancers following pregnancy and an associated gene expression signature.
        Springerplus. 2015; 4: 710
        • Peri S.
        • de Cicco R.L.
        • Santucci-Pereira J.
        • et al.
        Defining the genomic signature of the parous breast.
        BMC Med Genomics. 2012; 5: 1
        • Lyons T.R.
        • Schedin P.J.
        • Borges V.F.
        Pregnancy and breast cancer: when they collide.
        J Mammary Gland Biol Neoplasia. 2009; 14: 87-98
        • Schedin P.
        Pregnancy-associated breast cancer and metastasis.
        Nat Rev Cancer. 2006; 6: 281-291
        • Yager J.D.
        • Davidson N.E.
        Estrogen carcinogenesis in breast cancer.
        N Engl J Med. 2006; 354: 270-282
        • Burtrum D.
        • Zhu Z.
        • Lu D.
        • et al.
        A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
        Cancer Res. 2003; 63: 8912-8921
        • Gottardis M.M.
        • Wagner R.J.
        • Borden E.C.
        • Jordan V.C.
        Differential ability of antiestrogens to stimulate breast cancer cell (MCF-7) growth in vivo and in vitro.
        Cancer Res. 1989; 4: 4765-4769
        • Gupta P.B.
        • Proia D.
        • Cingoz O.
        • et al.
        Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers.
        Cancer Res. 2007; 67: 2062-2071
        • Shakhar K.
        • Valdimarsdottir H.B.
        • Bovbjerg D.H.
        Heightened risk of breast cancer following pregnancy: could lasting systemic immune alterations contribute?.
        Cancer Epidemiol Biomarkers Prev. 2007; 16: 1082-1086
        • Strange R.
        • Li F.
        • Saurer S.
        • Burkhardt A.
        • Friis R.R.
        Apoptotic cell death and tissue remodelling during mouse mammary gland involution.
        Development. 1992; 115: 49-58
        • Lund L.R.
        • Romer J.
        • Thomasset N.
        • et al.
        Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways.
        Development. 1996; 122: 181-193
        • Watson C.J.
        • Kreuzaler P.A.
        Remodeling mechanisms of the mammary gland during involution.
        Int J Dev Biol. 2011; 55: 757-762
        • O’Brien J.
        • Lyons T.
        • Monks J.
        • et al.
        Alternatively activated macrophages and collagen remodelling characterize the postpartum involuting mammary gland across species.
        Am J Pathol. 2010; 176: 1241-1255
        • Hou N.
        • Ogundiran T.
        • Ojengbede O.
        • et al.
        Risk factors for pregnancy-associated breast cancer: a report from the Nigerian Breast Cancer Study.
        Ann Epidemiol. 2013; 23: 551-557
        • Johannsson O.
        • Loman N.
        • Borg A.
        • Olsson H.
        Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carriers.
        Lancet. 1998; 352: 1359-1360
        • Jernström H.
        • Lerman C.
        • Ghadirian P.
        • et al.
        Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2.
        Lancet. 1999; 354: 1846-1850
        • Andrieu N.
        • Goldgar D.E.
        • Easton D.F.
        • et al.
        Pregnancies, breast-feeding, and breast cancer risk in the international BRCA1/2 carrier cohort study (IBCCS).
        J Natl Cancer Inst. 2006; 98: 535-544
        • Robertson C.
        • Primic-Zakelj M.
        • Boyle P.
        • Hsieh C.C.
        Effect of parity and age at delivery on breast cancer risk in Slovenian women aged 25-54 years.
        Int J Cancer. 1997; 73: 1-9
        • Kim Y.G.
        • Jeon Y.W.
        • Ko B.K.
        • et al.
        • Korean Breast Cancer Society
        Clinicopathologic characteristics of pregnancy-associated breast cancer: results of analysis of a nationwide breast cancer registry database.
        J Breast Cancer. 2017; 20: 264-269
        • Sisti J.S.
        • Collins L.C.
        • Beck A.H.
        • Tamimi R.M.
        • Rosner B.A.
        • Eliassen A.H.
        Reproductive risk factors in relation to molecular subtypes of breast cancer: results from the nurses' health studies.
        Int J Cancer. 2016; 138: 2346-2356
        • Tamimi R.M.
        • Colditz G.A.
        • Hazra A.
        • et al.
        Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer.
        Breast Cancer Res Treat. 2012; 131: 159-167
        • Millikan R.C.
        • Newman B.
        • Tse C.-K.
        • et al.
        Epidemiology of basal-like breast cancer.
        Breast Cancer Res Treat. 2008; 109: 123-139
        • Yang X.R.
        • Sherman M.E.
        • Rimm D.L.
        • et al.
        Differences in risk factors for breast cancer molecular subtypes in a population-based study.
        Cancer Epidemiol Biomark Prev. 2007; 16: 439-443
        • Li C.I.
        • Beaber E.F.
        • Tang M.-T.C.
        • Porter P.L.
        • Daling J.R.
        • Malone K.E.
        Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age.
        Breast Cancer Res Treat. 2013; 137: 579-587
        • Phipps A.I.
        • Buist D.S.M.
        • Malone K.E.
        • et al.
        Reproductive history and risk of three breast cancer subtypes defined by three biomarkers.
        Cancer Causes Control. 2011; 22: 399-405
        • Ambrosone C.B.
        • Zirpoli G.
        • Hong C.-C.
        • et al.
        Important role of menarche in development of estrogen receptor-negative breast cancer in African American women.
        J Natl Cancer Inst. 2015; 107: djv172
        • Chowdhury R.
        • Sinha B.
        • Sankar M.J.
        • et al.
        Breastfeeding and maternal health outcomes: a systematic review and meta-analysis.
        Acta Paediatr. 2015; 104: 96-113
        • Collaborative Group on Hormonal Factors in Breast Cancer
        Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease.
        Lancet. 2002; 360: 187-195
        • ElShamy W.M.
        The protective effect of longer duration of breastfeeding against pregnancy-associated triple negative breast cancer.
        Oncotarget. 2016; 7: 53941-53950
        • Bonnier P.
        • Romain S.
        • Dilhuydy J.M.
        • et al.
        Influence of pregnancy on the outcome of breast cancer: a case-control study. Societe Francaise de Senologie et de Pathologie Mammaire Study Group.
        Int J Cancer. 1997; 72: 720-727
        • Murphy C.G.
        • Mallam D.
        • Stein S.
        • et al.
        Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancer.
        Cancer. 2012; 118: 3254-3259
        • Genin A.S.
        • Lesieur B.
        • Gligorov J.
        • Antoine M.
        • Selleret L.
        • Rouzier R.
        Pregnancy-associated breast cancers: do they differ from other breast cancers in young women?.
        Breast. 2012; 21: 550-555
        • Madaras L.
        • Kovács K.A.
        • Szász A.M.
        • et al.
        Clinicopathological features and prognosis of pregnancy associated breast cancer—a matched case control study.
        Pathol Oncol Res. 2014; 20: 581-590
        • Azim Jr., H.A.
        • Brohée S.
        • Peccatori F.A.
        • et al.
        Biology of breast cancer during pregnancy using genomic profiling.
        Endocr Relat Cancer. 2014; 21: 545-554
        • Azim Jr., H.A.
        • Peccatori F.A.
        • Brohée S.
        • et al.
        RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy.
        Breast Cancer Res. 2015; 17: 24
        • Azim Jr., H.A.
        • Vingiani A.
        • Peccatori F.
        • Viale G.
        • Loi S.
        • Pruneri G.
        Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy.
        Breast. 2015; 24: 290-293
        • Hsiao Y.H.
        • Su Y.A.
        • Tsai H.D.
        • Mason J.T.
        • Chou M.C.
        • Man Y.G.
        Increased invasiveness and aggressiveness in breast epithelia with cytoplasmic p63 expression.
        Int J Biol Sci. 2010; 6: 428-442
        • Woo J.C.
        • Yu T.
        • Hurd T.C.
        Breast cancer in pregnancy: a literature review.
        Arch Surg. 2003; 138: 91-99
        • Litton J.K.
        • Theriault R.L.
        • Gonzalez-Angulo A.M.
        Breast cancer diagnosis during pregnancy.
        Womens Health (Lond Engl). 2009; 5: 243-249
        • Robbins J.
        • Jeffries D.
        • Roubidoux M.
        • et al.
        Accuracy of diagnostic mammography and breast ultrasound during pregnancy and lactation.
        AJR Am J Roentgenol. 2011; 196: 716-722
        • Yang W.T.
        • Dryden M.J.
        • Gwyn K.
        • Whitman G.J.
        • Theriault R.
        Imaging of breast cancer diagnosed and treated with chemotherapy during pregnancy.
        Radiology. 2006; 239: 52-60
        • Padmagirison R.
        • Gajjar K.
        • Spencer C.
        Management of breast cancer during pregnancy.
        Obstet Gynecol. 2010; 12: 186-192
        • International Commission on Radiological Protection
        The 2007 recommendations of the International Commission on Radiological Protection.
        Ann ICRP. 2007; 37: 1-332
        • Vashi R.
        • Hooley R.
        • Butler R.
        • et al.
        Breast imaging of the pregnant and lactating patient: physiologic changes and common benign entities.
        AJR Am J Roentgenol. 2013; 200: 329-336
        • Vinatier E.
        • Merlot B.
        • Poncelet E.
        • Collinet P.
        • Vinatier D.
        Breast cancer during pregnancy.
        Eur J Obstet Gynecol Reprod Biol. 2009; 147: 9-14
        • Rovera F.
        • Frattini F.
        • Coglitore A.
        • et al.
        Breast cancer in pregnancy.
        Breast J. 2010; 16: S22-S25
        • Nguyen C.P.
        • Goodman L.H.
        Foetal risk in diagnostic radiology.
        Semin Ultrasound CT MR. 2012; 33: 4-10
        • American College of Radiology
        ACR Manual on Contrast Media.
        (Available at:) (Accessed: April 4, 2020)
        • National Comprehensive Cancer Network
        NCCN Guidelines, version 1.2018: Breast Cancer.
        (Available at:) (Accessed: April 4, 2020)
        • Hegewald M.J.
        • Crapo R.O.
        Respiratory physiology in pregnancy.
        Clin Chest Med. 2011; 32: 1-13
        • Hawkins J.L.
        • Chang J.
        • Palmer S.K.
        • Gibbs C.P.
        • Callaghan W.M.
        Anesthesia-related maternal mortality in the United States: 1979-2002.
        Obstet Gynecol. 2011; 117: 69-74
        • Iscan Z.H.
        • Mavioglu L.
        • Vural K.M.
        • Kucuker S.
        • Birincioglu L.
        Cardiac surgery during pregnancy.
        J Heart Valve Dis. 2006; 15: 686-690
        • Anderson J.A.
        • Weitz J.I.
        Hypercoagulable states.
        Crit Care Clin. 2011; 27: 933-952
        • Wong C.A.
        • McCarthy R.J.
        • Fitzgerald P.C.
        • Raikoff K.
        • Avram M.J.
        Gastric emptying of water in obese pregnant women at term.
        Anesth Analg. 2007; 105: 751-755
        • Shiono P.H.
        • Mills J.L.
        Oral clefts and diazepam use during pregnancy.
        N Engl J Med. 1984; 311: 919-920
        • McElhatton P.R.
        The effects of benzodiazepine use during pregnancy and lactation.
        Reprod Toxicol. 1994; 8: 461-475
        • Peccatori F.A.
        • Azim Jr., H.A.
        • Orecchia R.
        • et al.
        Cancer, pregnancy and fertility: ESMO clinical practice guidelines for diagnosis, treatment and follow-up.
        Ann Oncol. 2013; 24: vi60-vi70
        • Toesca A.
        • Gentilini O.
        • Peccatori F.
        • Azim Jr., H.A.
        • Amant F.
        Locoregional treatment of breast cancer during pregnancy.
        Gynecol Surg. 2014; 11: 279-284
        • Gentilini O.
        • Cremonesi M.
        • Trifirò G.
        • et al.
        Safety of sentinel node biopsy in pregnant patients with breast cancer.
        Ann Oncol. 2004; 15: 1348-1351
        • Gentilini O.
        • Cremonesi M.
        • Toesca A.
        • et al.
        Sentinel lymph node biopsy in pregnant patients with breast cancer.
        Eur J Nucl Med Mol Imaging. 2010; 37: 78-93
        • Mondi M.M.
        • Cuenca R.E.
        • Ollila D.W.
        • et al.
        Sentinel lymph node biopsy during pregnancy: initial clinical experience.
        Ann Surg Oncol. 2007; 14: 218-221
        • Spanheimer P.M.
        • Graham M.M.
        • Sugg S.L.
        • et al.
        Measurement of uterine radiation exposure from lymphoscintigraphy indicates safety of sentinel lymph node biopsy during pregnancy.
        Ann Surg Oncol. 2009; 16: 1143-1147
        • Morita E.T.
        • Chang J.
        • Leong S.P.
        Principles and controversies in lymphoscintigraphy with emphasis on breast cancer.
        Surg Clin North Am. 2000; 80: 1721-1739
        • Keleher A.
        • Wendt III, R.
        • Delpassand E.
        • et al.
        The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid.
        Breast J. 2004; 10: 492-495
        • te Velde E.A.
        • Sonke G.
        • Rutgers E.J.
        Breast cancer and pregnancy: diagnosis and treatment options.
        Breast Cancer Online. 2009; 12: e10
        • Pruthi S.
        • Haakkenson C.
        • Brost B.C.
        • et al.
        Pharmacokinetics of methylene blue dye for lymphatic mapping in breast cancer—implications for use in pregnancy.
        Am J Surg. 2011; 201: 70-75
        • Lohsiriwat V.
        • Peccatori F.A.
        • Martella S.
        • et al.
        Immediate breast reconstruction with expander in pregnant breast cancer patients.
        Breast. 2013; 22: 657-660
        • Caragacianu D.L.
        • Mayer E.L.
        • Chun Y.S.
        • et al.
        Immediate breast reconstruction following mastectomy in pregnant women with breast cancer.
        J Surg Oncol. 2016; 114: 140-143
        • Chirappapha P.
        • Thaweepworadej P.
        • Ngamphaiboon N.
        • Sukprasert M.
        • Sukarayothin T.
        • Leesombatpaiboon M.
        Breast reconstruction in pregnancy: a case report of multidisciplinary team approach in immediate autologous flap reconstruction for pregnancy-associated breast cancer.
        Clin Case Rep. 2017; 5: 1450-1453
        • Amant F.
        • von Minckwitz G.
        • Han S.N.
        • et al.
        Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study.
        J Clin Oncol. 2013; 31: 2532-2539
        • Ploquin A.
        • Pistilli B.
        • Tresch E.
        • et al.
        5-Year overall survival after early breast cancer diagnosed during pregnancy: a retrospective case-control multicentre French study.
        Eur J Cancer. 2018; 95: 30-37
        • Loibl S.
        • Schmidt A.
        • Gentilini O.
        • et al.
        Breast cancer diagnosed during pregnancy: adapting recent advances in breast cancer care for pregnant patients.
        JAMA Oncol. 2015; 1: 1145-1153
        • Paskulin G.A.
        • Gazzola Zen P.R.
        • de Camargo Pinto L.L.
        • Rosa R.
        • Graziadio C.
        Combined chemotherapy and teratogenicity.
        Birth Defects Res Part A Clin Mol Teratol. 2005; 73: 634-637
        • Ring A.E.
        • Smith I.E.
        • Jones A.
        • Shannon C.
        • Galani E.
        • Ellis P.A.
        Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals.
        J Clin Oncol. 2005; 23: 4192-4197
        • Centers for Disease Control and Prevention, National Center for Health and Statistics
        Birth defects: data and statistics.
        (Available at:)
        • Azim Jr., H.A.
        • Del Mastro L.
        • Scarfone G.
        • Peccatori F.A.
        Treatment of breast cancer during pregnancy: regimen selection, pregnancy monitoring and more.
        Breast. 2011; 20: 1-6
        • Cardonick E.
        • Dougherty R.
        • Grana G.
        • Gilmandyar D.
        • Ghaffar S.
        • Usmani A.
        Breast cancer during pregnancy: maternal and foetal outcomes.
        Cancer J. 2010; 16: 76-82
        • Hahn K.M.
        • Johnson P.H.
        • Gordon N.
        • et al.
        Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero.
        Cancer. 2006; 107: 1219-1226
        • Loibl S.
        • Han S.N.
        • von Minckwitz G.
        • et al.
        Treatment of breast cancer during pregnancy: an observational study.
        Lancet Oncol. 2012; 13: 887-896
        • Peccatori F.A.
        • Azim Jr., H.A.
        • Scarfone G.
        • et al.
        Weekly epirubicin in the treatment of gestational breast cancer (GBC).
        Breast Cancer Res Treat. 2009; 115: 591-594
        • Peccatori F.A.
        • Lambertini M.
        • Scarfone G.
        • Del Pup L.
        • Codacci-Pisanelli G.
        Biology, staging, and treatment of breast cancer during pregnancy: reassessing the evidences.
        Cancer Biol Med. 2018; 15: 6-13
        • Mir O.
        • Berveiller P.
        • Goffinet F.
        • et al.
        Taxanes for breast cancer during pregnancy: a systematic review.
        Ann Oncol. 2010; 21: 425-426
        • Zagouri F.
        • Sergentanis T.N.
        • Chrysikos D.
        • et al.
        Taxanes for breast cancer during pregnancy: a systematic review.
        Clin Breast Cancer. 2013; 13: 16-23
        • Cardonick E.
        • Bhat A.
        • Gilmandyar D.
        • Somer R.
        Maternal and foetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature.
        Ann Oncol. 2012; 23: 3016-3023
        • Sparano J.A.
        • Zhao F.
        • Martino S.
        • et al.
        Long-term follow-up of the E1199 phase III trial evaluating the role of taxane and schedule in operable breast cancer.
        J Clin Oncol. 2015; 33: 2353-2360
        • Van Calsteren K.
        • Heyns L.
        • De Smet F.
        • et al.
        Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes.
        J Clin Oncol. 2010; 28: 683-689
        • Moja L.
        • Tagliabue L.
        • Balduzzi S.
        • et al.
        Trastuzumab containing regimens for early breast cancer.
        Cochrane Database Syst Rev. 2012; 4: CD006243
        • Lee K.F.
        • Simon H.
        • Chen H.
        • Bates B.
        • Hung M.C.
        • Hauser C.
        Requirement for neuregulin receptor erbB2 in neural and cardiac development.
        Nature. 1995; 378: 394-398
        • Azim Jr., H.A.
        • Azim H.
        • Peccatori F.A.
        Treatment of cancer during pregnancy with monoclonal antibodies: a real challenge.
        Exp Rev Clin Immunol. 2010; 6: 821-826
        • Shachar S.S.
        • Gallagher K.
        • McGuire K.
        • et al.
        Multidisciplinary management of breast cancer during pregnancy.
        Oncologist. 2017; 22: 324-334
        • Cullins S.L.
        • Pridjian G.
        • Sutherland C.M.
        Goldenhar's syndrome associated with tamoxifen given to the mother during gestation.
        JAMA. 1994; 271: 1905-1906
        • Isaacs R.J.
        • Hunter W.
        • Clark K.
        Tamoxifen as systemic treatment of advanced breast cancer during pregnancy—case report and literature review.
        Gynecol Oncol. 2001; 80: 405-408
        • Braems G.
        • Denys H.
        • De Wever O.
        • et al.
        Use of tamoxifen before and during pregnancy.
        Oncologist. 2011; 16: 1547-1551
        • Stathopoulos I.P.
        • Liakou C.G.
        • Katsalira A.
        • et al.
        The use of bisphosphonates in women prior to or during pregnancy and lactation.
        Hormones (Athens). 2011; 10: 280-291
        • Smith H.S.
        • Cox L.R.
        • Smith E.J.
        5-HT3 receptor antagonists for the treatment of nausea/vomiting.
        Ann Palliat Med. 2012; 1: 115-120
        • Calhoun D.A.
        • Christensen R.D.
        A randomized pilot trial of administration of granulocyte colony-stimulating factor to women before preterm delivery.
        Am J Obstet Gynecol. 1998; 179: 766-771
        • Schneider H.
        • Malek A.
        Lack of permeability of the human placenta for erythropoietin.
        J Perinat Med. 1995; 23: 71-76
        • Broe A.
        • Pottegård A.
        • Lamont R.F.
        • et al.
        Increasing use of antibiotics in pregnancy during the period 2000-2010: prevalence, timing, category, and demographics.
        BJOG. 2014; 121: 988-996
        • Peccatori F.A.
        • Corrado G.
        • Fumagalli M.
        Risk factors: after gestational chemotherapy, the kids are all right.
        Nat Rev Clin Oncol. 2015; 12: 254-255
        • D’Cruz C.M.
        • Moody S.E.
        • Master S.R.
        • et al.
        Persistent parity-induced changes in growth factors, TGF-b3, and differentiation in the rodent mammary gland.
        Mol Endocrinol. 2002; 16: 2034-2051
        • Nguyen B.
        • Venet D.
        • Azim H.A.
        • et al.
        Breast cancer diagnosed during pregnancy is associated with enrichment of non-silent mutations, mismatch repair deficiency signature and mucin mutations.
        Breast Cancer. 2018; 23: 1-7